5.61
Cellectar Biosciences, Inc.
Metrics score locked — part of Premium
FY23
FY23
FY23
FY24
FY25
FY23 – FY25
Assets
(positive)
Change from FY23 to FY25
millions USD
FY23:
FY23:
20.1
FY23:
10.5
FY24:
24.3
FY25:
14.0
(positive)
Change from FY23 to FY25
millions USD
FY23:
0.90
FY23:
1.44
FY23:
1.62
FY24:
1.22
FY25:
0.94
Total assets
Change from FY23 to FY25
millions USD
FY23:
6.51
FY23:
21.6
FY23:
12.1
FY24:
25.5
FY25:
15.0
Liabilities & Equity
(negative)
Change from FY23 to FY25
millions USD
FY23:
13.0
FY23:
29.8
FY23:
25.4
FY24:
9.39
FY25:
4.75
(negative)
Change from FY23 to FY25
millions USD
FY23:
0.53
FY23:
0.51
FY23:
0.49
FY24:
0.41
FY25:
0.31
(positive)
Change from FY23 to FY25
millions USD
FY23:
−8.39
FY23:
−28.0
FY23:
−15.2
FY24:
14.3
FY25:
8.54
All amounts in millions USD